INS and cancer: There were also significant interactions between insulin-expressing cancer cells and immune cells, namely CD40LG (INS+FOSlow, INS+) − CD40 (B cell) and APP (INS+) − TREM2 + TYROBP (macrophage) (Fig. 6 B, D, Supplementary Table 14).